Age: 31
Free Agency: 2025 (SFA)
Accrued Seasons: 6
- Height: 5'11"
- Weight: 186
- College: USC
- Entry: 2016 Draft, Round 6, #218 overall (Bills)
- 2024 Salary Cap Charge: $243,844 (0.09% of cap)
- 2024 Cash Payout: $268,844 (0.10% of spending)
- 2024 Cash to Cap Ratio: 1.10
- Contract Value: $369,644 ($369,644 APY)
- Fully Guaranteed Money: $0
- Contract Ranking: 231/290 at CB
Current Contract
(Practice, signed 2024)
(📝: indicates contract trigger occuring during that year)| Year | Age | Base Salary | Cap Number | Cap % | Dead Money & Cap Savings | |||
|---|---|---|---|---|---|---|---|---|
| 2024 | 31 | $302,400 | $243,844 | 0.1% | ||||
| Total | $302,400 | $243,844 | ||||||
Contract Notes
Kevon Seymour was traded to the Panthers on September 2, 2017. Seymour has three years remaining on his rookie contract, none of which are guaranteed.
Cash Flows
- old money
- fully earned money
- unearned or partially earned money
$0.4M
| Old Money | 2024 | |
|---|---|---|
| Cash Due | $67,244 | $302,400 |
| Running Cash | $369,644 |
Career Earnings: $4,616,311
Career APY: $659,473
Potential Earnings: $3,489,900
Total Guarantees: $200,712
Largest Cash Payment: $804,167 (2022)
Largest Cap Number: $804,167 (2022)
Contract History
| Team | Contract Type | Status | Year Signed | Yrs | Total | APY | Guarantees | Amount Earned | % Earned | Effective APY |
|---|---|---|---|---|---|---|---|---|---|---|
| Bills | Drafted | Traded | 2016 | 4 | $2,440,356 | $610,089 | $100,356 | $550,356 | 22.6% | $550,356 |
| Panthers | Drafted | Terminated | 2016 | 4 | $2,440,356 | $610,089 | $100,356 | $1,170,000 | 47.9% | $585,000 |
| Eagles | Practice | Renegotiated | 2020 | 1 | $204,000 | $204,000 | $0 | $0 | 0.0% | $0 |
| Eagles | SFA | Terminated | 2020 | 2 | $1,670,000 | $835,000 | $0 | $141,177 | 8.5% | $141,177 |
| Eagles | SFA | Terminated | 2021 | 1 | $850,000 | $850,000 | $0 | $0 | 0.0% | $0 |
| Ravens | Practice | Elevated | 2021 | 1 | $252,000 | $252,000 | $0 | $0 | 0.0% | $0 |
| Ravens | Practice | Renegotiated | 2021 | 1 | $341,555 | $341,555 | $0 | $0 | 0.0% | $0 |
| Ravens | Practice | Elevated | 2021 | 1 | $275,111 | $275,111 | $0 | $0 | 0.0% | $0 |
| Ravens | SFA | Expired | 2021 | 1 | $850,000 | $850,000 | $0 | $330,556 | 38.9% | $330,556 |
| Ravens | UFA | Terminated | 2022 | 1 | $965,000 | $965,000 | $0 | $0 | 0.0% | $0 |
| Ravens | Practice | Renegotiated | 2022 | 1 | $358,200 | $358,200 | $0 | $0 | 0.0% | $0 |
| Ravens | SFA | Expired | 2022 | 1 | $965,000 | $965,000 | $0 | $804,167 | 83.3% | $804,167 |
| Ravens | UFA | Terminated | 2023 | 1 | $1,080,000 | $1,080,000 | $0 | $0 | 0.0% | $0 |
| Ravens | SFA | Terminated | 2023 | 1 | $1,080,000 | $1,080,000 | $0 | $0 | 0.0% | $0 |
| Ravens | Practice | Elevated | 2023 | 1 | $370,800 | $378,000 | $0 | $0 | 0.0% | $0 |
| Ravens | Practice | Expired | 2023 | 1 | $370,800 | $370,800 | $0 | $224,800 | 60.6% | $224,800 |
| Commanders | Practice | Elevated | 2024 | 1 | $302,400 | $302,400 | $0 | $0 | 0.0% | $0 |
| Commanders | Practice | Elevated | 2024 | 1 | $319,222 | $319,222 | $0 | $0 | 0.0% | $0 |
| Commanders | Practice | Active | 2024 | 1 | $369,644 | $369,644 | $0 | $0 | 0.0% | $0 |
Earnings By Team
| Team | Yrs | Salary | APY | Paid on Cap | % Paid on Cap | Paid as Dead Money | % Paid as Dead Money |
|---|---|---|---|---|---|---|---|
| Bills | 1 | $550,356 | $550,356 | $475,089 | 0.0% | $75,267 | 0.0% |
| Panthers | 2 | $1,170,000 | $585,000 | $1,170,000 | 0.0% | $288,000 | 0.0% |
| Eagles | 1 | $153,177 | $153,177 | $141,177 | 0.0% | $12,000 | 0.0% |
| Ravens | 3 | $2,742,778 | $914,259 | $1,351,745 | 0.0% | $1,243,255 | 0.0% |
| Commanders | 0 | $0 | $0 | $0 | 0.0% | $0 | 0.0% |
Season History
| Year | Team | Base Salary | Prorated Bonus | Cap Number | Cap % | Cash Paid | |
|---|---|---|---|---|---|---|---|
| 2016 | Bills | $450,000 | $25,089 | $475,089 | 0.3% | $550,356 | |
| 2017 | Panthers | $540,000 | $0 | $540,000 | 0.3% | $540,000 | |
| 2018 | Panthers | $630,000 | $0 | $630,000 | 0.3% | $630,000 | |
| 2020 | Eagles | $750,000 | $0 | $141,177 | 0.1% | $141,177 | |
| 2021 | Ravens | $850,000 | $0 | $330,556 | 0.2% | $330,556 | |
| 2022 | Ravens | $965,000 | $0 | $804,167 | 0.4% | $804,167 | |
| 2023 | Ravens | $370,800 | $0 | $217,022 | 0.1% | $224,800 | |
| 2024 | Commanders | $302,400 | $0 | $243,844 | 0.1% | $268,844 | |
| Total | $4,858,200 | $25,089 | $3,381,855 | $3,489,900 | |||
Statistics
| Year | Games Played | Games Inactive | Snaps | Tackles | Negative Plays | Interceptions | Fumbles | TD | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Injured | Healthy | Defense | Special | Solo | Assist | Sacks | Yards | TFL | QB Hits | Pass Def. | INT | Yards | Forced | Rec. | Yards | |||
| 2016 | 15 | 1 | 0 | 26.5% | 41.0% | 11 | 2 | 0 | 0 | 0 | 0 | 3 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2017 | 16 | 0 | 0 | 31.9% | 42.8% | 18 | 4 | 0 | 0 | 0 | 1 | 4 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2020 | 2 | 0 | 0 | 7.4% | 5.4% | 5 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2021 | 9 | 0 | 0 | 22.7% | 33.5% | 15 | 8 | 1 | 9 | 3 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2022 | 13 | 0 | 0 | 0.5% | 60.6% | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2023 | 8 | 1 | 0 | 1.1% | 32.8% | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2024 | 2 | 0 | 0 | 0.0% | 4.8% | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Valuation Diamond
The diamond is a scatterplot graph that visualizes the relation of the player's APY (in green) and performance (in blue, as measured by OTC's Valuations) to the rest of the league at his position. To understand how to read the diamond, read this explainer.
| OTC Valuation | APY | |
|---|---|---|
| Regular | $0 | $0 |
| Injury Adjusted | $0 | $0 |
test
Weekly Valuation Trends
The chart below illustrates the trend of the player's weekly OTC Valuations (in blue) from the most recent season, using APY (in green) and, if applicable, cash that is due to the player in the next season (in red) as benchmarks. Weeks not plotted indicate that the player was inactive or on a bye.
To see interactive and more in-depth use of OTC Valuation data, subscribe to OTC Premium.